Department of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, Suedring 15, 79189, Bad Krozingen, Germany.
Department of Surgery, Ortenau Klinikum Lahr, Lahr, Germany.
Clin Res Cardiol. 2020 May;109(5):589-598. doi: 10.1007/s00392-019-01546-3. Epub 2019 Sep 25.
Identifying factors associated with worse outcome following carotid endarterectomy (CEA) is important to improve prevention of major adverse cardiovascular and cerebrovascular events (MACCE), yet rarely used for registries. We intended to identify predictors of MACCE following CEA as recently analysed for stenting.
Patients undergoing CEA at 2 centers over 13 years were entered into a database. Baseline clinical characteristics, procedural factors and a panel of clinical and lesion-related high-risk features (SHR) and exclusion criteria (SE), empirically compiled for stratification in the SAPPHIRE trial, were differentially analysed using Cox regressions. The analysis included 748 operations; 262 (35%) asymptomatic, 208 (28%) with previous strokes, and 278 (37%) with transient ischemic attacks (TIA). The overall 30-day MACCE rate was 6.7%, 5.0% in asymptomatic and 7.6% in symptomatic patients. Previous MI (HR 2.045, p = 0.022), diabetes (HR 2.111, p = 0.011) and symptomatic patients (HR 2.045, p = 0.044) were independently associated with MACCE. SE patients (n = 81) had a MACCE rate of 13.6%; the MACCE rate of the remainder dropped to 5.8% (4.7% in asymptomatic and 6.5% in symptomatic patients). Hazard ratio for SHR patients was 2.069 (CI 1.087-3.941) and 2.389 for SE (CI 1.223-4.666), each compared to all patients with lower risk and adjusted for symptomatic status. Among SHR and SE criteria NYHA 3-4, contralateral occlusions and intraluminal thrombus were significant determinants and MI < 4 weeks before CEA showed a strong trend (p = 0.05).
Patients identified by SHR and SE criteria, prior MI and diabetes warrant increased attention to prevent MACCE following CEA.
识别颈动脉内膜切除术(CEA)后预后不良的相关因素对于改善主要不良心血管和脑血管事件(MACCE)的预防至关重要,但很少用于登记处。我们旨在确定最近在支架置入分析中CEA 后 MACCE 的预测因素。
对 13 年来在 2 个中心接受 CEA 的患者进行了数据库登记。使用 Cox 回归分析对基线临床特征、手术因素和一组临床和病变相关高危特征(SHR)和排除标准(SE)进行差异分析,这些特征是为 SAPPHIRE 试验分层经验性组合的。分析包括 748 例手术;262 例(35%)无症状,208 例(28%)有既往卒中,278 例(37%)有短暂性脑缺血发作(TIA)。总的 30 天 MACCE 发生率为 6.7%,无症状患者为 5.0%,有症状患者为 7.6%。既往心肌梗死(HR 2.045,p=0.022)、糖尿病(HR 2.111,p=0.011)和有症状患者(HR 2.045,p=0.044)与 MACCE 独立相关。SE 患者(n=81)MACCE 发生率为 13.6%;其余患者的 MACCE 发生率降至 5.8%(无症状患者为 4.7%,有症状患者为 6.5%)。SHR 患者的危险比为 2.069(CI 1.087-3.941),SE 患者为 2.389(CI 1.223-4.666),与所有低风险患者相比,并且调整了症状状态。在 SHR 和 SE 标准中,NYHA 3-4、对侧闭塞和管腔内血栓是重要的决定因素,MI 在 CEA 前<4 周显示出强烈的趋势(p=0.05)。
通过 SHR 和 SE 标准、既往 MI 和糖尿病识别的患者需要更加注意预防 CEA 后 MACCE。